3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
10
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Interventions
trilaciclib
1
rovalpituzumab tesirine
1
epigallocatechin gallate
1
dabrafenib
1
PM 01183
1
BID protein, human
1
AMG 757
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Small Cell Lung Carcinoma
×
rovalpituzumab tesirine
×
Clear all
NCT03503890
2019-09-10
Expanded Access to Rovalpituzumab Tesirine
AbbVie
No longer available